Technical Analysis for CMRX - Chimerix, Inc.

Grade Last Price % Change Price Change
grade F 2.01 -0.99% -0.02
CMRX closed down 0.99 percent on Wednesday, March 20, 2019, on approximately normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CMRX trend table...

Date Alert Name Type % Chg
Mar 20 Shooting Star Candlestick Bearish 0.00%
Mar 20 Lizard Bearish Bearish Day Trade Setup 0.00%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 20 Doji - Bearish? Reversal 0.00%
Mar 20 Outside Day Range Expansion 0.00%
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.99%
Mar 19 Narrow Range Bar Range Contraction -0.99%
Mar 19 NR7 Range Contraction -0.99%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.50%
Mar 18 Narrow Range Bar Range Contraction -0.50%

Older signals for CMRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Chimerix, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of oral antiviral therapeutics for various medical needs. Its lead product includes CMX001, an orally administered drug that has completed Phase II clinical trials for the prevention of cytomegalovirus infection in hematopoietic stem cell transplant recipients; and is in Phase II clinical trials for treating double-stranded DNA viruses comprising herpesviruses, adenoviruses, BK viruses, papillomaviruses, and orthopoxviruses, as well as for the treatment of smallpox. The company also develops CMX157, an oral nucleotide compound that is in Phase I clinical trials to treat HIV infections. It has a collaboration and license agreement with Merck, Sharp & Dohme Corp. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.
Medicine Chemistry Biopharmaceutical Antiviral Drug Virus Antivirals Prodrugs Ebola
Is CMRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.6
52 Week Low 1.74
Average Volume 403,787
200-Day Moving Average 3.4861
50-Day Moving Average 2.2674
20-Day Moving Average 1.9845
10-Day Moving Average 1.926
Average True Range 0.1534
ADX 18.18
+DI 24.7414
-DI 16.6014
Chandelier Exit (Long, 3 ATRs ) 1.9698
Chandelier Exit (Short, 3 ATRs ) 2.2002
Upper Bollinger Band 2.2542
Lower Bollinger Band 1.7148
Percent B (%b) 0.55
BandWidth 27.18065
MACD Line -0.067
MACD Signal Line -0.0985
MACD Histogram 0.0315
Fundamentals Value
Market Cap 94.56 Million
Num Shares 47 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -1.41
Price-to-Sales 53.42
Price-to-Book 0.94
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.24
Resistance 3 (R3) 2.26 2.20 2.20
Resistance 2 (R2) 2.20 2.15 2.19 2.18
Resistance 1 (R1) 2.11 2.11 2.08 2.09 2.17
Pivot Point 2.05 2.05 2.04 2.04 2.05
Support 1 (S1) 1.96 2.00 1.93 1.94 1.85
Support 2 (S2) 1.90 1.96 1.89 1.84
Support 3 (S3) 1.81 1.90 1.82
Support 4 (S4) 1.79